Glucose Monitoring and Biometric Sensor

This portfolio represents compelling 2017–2019 priority dates, clear disruptive potential, and inarguable relevance for major incumbents such as Apple and Samsung. The patents are highly innovative — covering non-invasive glucose measurement and multimodal biometric sensing that fuses oxygen, heart rate, and blood-flow data to enable continuous, contactless health insight.